| Jaroslaw P Sasanka, MD | |
|
31685 Temecula Pkwy Ste B, Temecula, CA 92592-2872 | |
| (951) 302-5700 | |
| (951) 302-0555 |
| Full Name | Jaroslaw P Sasanka |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 31685 Temecula Pkwy Ste B, Temecula, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497787964 | NPI | - | NPPES |
| 1497787964 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | C52304 (California) | Primary |
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
Mammographically-dense breasts - those that show more breast and connective tissue versus fat in a mammogram image - are recognized as a risk factor for developing breast cancer and can also hamper an accurate reading of a mammogram. National legislation currently under consideration would require the disclosure of mammographic breast density information to women with dense breasts, as well as encourage the consideration of supplemental screening for those women.
One of the most comprehensive investigations done to date on aromatherapy failed to show any improvement in either immune status, wound healing or pain control among people exposed to two often-touted scents.
Florence Nightingale once said that apprehension, uncertainty, waiting, expectation and fear of surprise do a patient more harm than any exertion. This valuable philosophy is shared by today's nurses, social workers and other healthcare professionals as they work to educate every patient - before, during and after their treatment, leaving no question unanswered.
Warning that patients could be at risk, an interdisciplinary group of multinational investigators is calling on the U.S. Congress and federal regulators to tighten a law that permits use of brain devices to treat rare neuropsychiatric disorders without supporting clinical trials or stringent patient oversight.
› Verified 7 days ago
| Entity Name | Riverside Emergency Physicians Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972539039 PECOS PAC ID: 0547173882 Enrollment ID: O20040729001307 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
Mammographically-dense breasts - those that show more breast and connective tissue versus fat in a mammogram image - are recognized as a risk factor for developing breast cancer and can also hamper an accurate reading of a mammogram. National legislation currently under consideration would require the disclosure of mammographic breast density information to women with dense breasts, as well as encourage the consideration of supplemental screening for those women.
One of the most comprehensive investigations done to date on aromatherapy failed to show any improvement in either immune status, wound healing or pain control among people exposed to two often-touted scents.
Florence Nightingale once said that apprehension, uncertainty, waiting, expectation and fear of surprise do a patient more harm than any exertion. This valuable philosophy is shared by today's nurses, social workers and other healthcare professionals as they work to educate every patient - before, during and after their treatment, leaving no question unanswered.
Warning that patients could be at risk, an interdisciplinary group of multinational investigators is calling on the U.S. Congress and federal regulators to tighten a law that permits use of brain devices to treat rare neuropsychiatric disorders without supporting clinical trials or stringent patient oversight.
› Verified 7 days ago
| Entity Name | Chase Dennis Emergency Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033152350 PECOS PAC ID: 2264345172 Enrollment ID: O20100819000855 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
Mammographically-dense breasts - those that show more breast and connective tissue versus fat in a mammogram image - are recognized as a risk factor for developing breast cancer and can also hamper an accurate reading of a mammogram. National legislation currently under consideration would require the disclosure of mammographic breast density information to women with dense breasts, as well as encourage the consideration of supplemental screening for those women.
One of the most comprehensive investigations done to date on aromatherapy failed to show any improvement in either immune status, wound healing or pain control among people exposed to two often-touted scents.
Florence Nightingale once said that apprehension, uncertainty, waiting, expectation and fear of surprise do a patient more harm than any exertion. This valuable philosophy is shared by today's nurses, social workers and other healthcare professionals as they work to educate every patient - before, during and after their treatment, leaving no question unanswered.
Warning that patients could be at risk, an interdisciplinary group of multinational investigators is calling on the U.S. Congress and federal regulators to tighten a law that permits use of brain devices to treat rare neuropsychiatric disorders without supporting clinical trials or stringent patient oversight.
› Verified 7 days ago
| Entity Name | Banning Medical Services A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164897849 PECOS PAC ID: 5193020576 Enrollment ID: O20160223000953 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
Mammographically-dense breasts - those that show more breast and connective tissue versus fat in a mammogram image - are recognized as a risk factor for developing breast cancer and can also hamper an accurate reading of a mammogram. National legislation currently under consideration would require the disclosure of mammographic breast density information to women with dense breasts, as well as encourage the consideration of supplemental screening for those women.
One of the most comprehensive investigations done to date on aromatherapy failed to show any improvement in either immune status, wound healing or pain control among people exposed to two often-touted scents.
Florence Nightingale once said that apprehension, uncertainty, waiting, expectation and fear of surprise do a patient more harm than any exertion. This valuable philosophy is shared by today's nurses, social workers and other healthcare professionals as they work to educate every patient - before, during and after their treatment, leaving no question unanswered.
Warning that patients could be at risk, an interdisciplinary group of multinational investigators is calling on the U.S. Congress and federal regulators to tighten a law that permits use of brain devices to treat rare neuropsychiatric disorders without supporting clinical trials or stringent patient oversight.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jaroslaw P Sasanka, MD 31685 Temecula Pkwy Ste B, Temecula, CA 92592-2872 Ph: (951) 302-5700 | Jaroslaw P Sasanka, MD 31685 Temecula Pkwy Ste B, Temecula, CA 92592-2872 Ph: (951) 302-5700 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
Mammographically-dense breasts - those that show more breast and connective tissue versus fat in a mammogram image - are recognized as a risk factor for developing breast cancer and can also hamper an accurate reading of a mammogram. National legislation currently under consideration would require the disclosure of mammographic breast density information to women with dense breasts, as well as encourage the consideration of supplemental screening for those women.
One of the most comprehensive investigations done to date on aromatherapy failed to show any improvement in either immune status, wound healing or pain control among people exposed to two often-touted scents.
Florence Nightingale once said that apprehension, uncertainty, waiting, expectation and fear of surprise do a patient more harm than any exertion. This valuable philosophy is shared by today's nurses, social workers and other healthcare professionals as they work to educate every patient - before, during and after their treatment, leaving no question unanswered.
Warning that patients could be at risk, an interdisciplinary group of multinational investigators is calling on the U.S. Congress and federal regulators to tighten a law that permits use of brain devices to treat rare neuropsychiatric disorders without supporting clinical trials or stringent patient oversight.
› Verified 7 days ago
Gordon S. Appelbaum, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 41540 Winchester Rd, Temecula, CA 92590 Phone: 951-365-5585 Fax: 951-404-7074 | |
Dr. Cindi L Marquette, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 43631 Calabro St, Temecula, CA 92592 Phone: 951-302-1625 Fax: 951-302-1625 | |
Dr. Jailyn Elizabeth Avila, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 31700 Temecula Pkwy, Temecula, CA 92592 Phone: 951-365-6865 | |
Dr. Rebecca Linda Sapien, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 28780 Single Oak Dr, Temecula, CA 92590 Phone: 714-826-9055 | |
Mckenna Perel, PA-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 31700 Temecula Pkwy, Temecula, CA 92592 Phone: 951-331-2200 |